ARCHIVES

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

September 3, 1982

Pauling Contends His Applications Included Essentials

April 27, 1979

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training

June 20, 1986

Environmental Emphasis Urged, Including New Role For Comp Centers NCAB Unenthusiastic

March 21, 1975